NPFFR1
Basic information
Region (hg38): 10:70247329-70284004
Previous symbols: [ "GPR147" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPFFR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 38 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 3 | 4 |
Variants in NPFFR1
This is a list of pathogenic ClinVar variants found in the NPFFR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-70255022-C-A | not specified | Uncertain significance (Nov 21, 2022) | ||
10-70255034-C-T | not specified | Uncertain significance (Dec 06, 2024) | ||
10-70255055-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
10-70255111-T-G | not specified | Uncertain significance (Dec 15, 2022) | ||
10-70255138-C-A | not specified | Uncertain significance (Jan 22, 2024) | ||
10-70255162-C-G | not specified | Uncertain significance (Apr 04, 2024) | ||
10-70255180-T-A | not specified | Uncertain significance (Mar 02, 2023) | ||
10-70255279-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
10-70255348-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
10-70255434-C-T | Benign (Jan 17, 2018) | |||
10-70255448-C-A | not specified | Uncertain significance (Apr 25, 2022) | ||
10-70255471-C-G | not specified | Uncertain significance (Aug 12, 2021) | ||
10-70255495-C-A | not specified | Uncertain significance (Nov 01, 2022) | ||
10-70255499-G-C | not specified | Uncertain significance (May 29, 2024) | ||
10-70255521-G-C | Likely benign (Mar 30, 2018) | |||
10-70255538-G-T | not specified | Uncertain significance (Dec 03, 2024) | ||
10-70255568-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
10-70255579-A-C | not specified | Uncertain significance (Jul 02, 2024) | ||
10-70255597-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
10-70255598-T-C | not specified | Likely benign (Jan 23, 2023) | ||
10-70255598-T-G | not specified | Uncertain significance (Mar 29, 2022) | ||
10-70255663-C-A | Benign (Mar 07, 2018) | |||
10-70255673-C-A | Benign (Jan 30, 2018) | |||
10-70255723-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
10-70255733-T-C | not specified | Uncertain significance (Jul 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPFFR1 | protein_coding | protein_coding | ENST00000277942 | 4 | 36348 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.55e-15 | 0.00144 | 124227 | 0 | 586 | 124813 | 0.00235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 202 | 270 | 0.747 | 0.0000176 | 2717 |
Missense in Polyphen | 67 | 99.789 | 0.67141 | 1085 | ||
Synonymous | 1.62 | 100 | 123 | 0.814 | 0.00000854 | 917 |
Loss of Function | -1.57 | 18 | 12.1 | 1.49 | 5.61e-7 | 122 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00283 | 0.00280 |
Ashkenazi Jewish | 0.00126 | 0.00119 |
East Asian | 0.000526 | 0.000501 |
Finnish | 0.000523 | 0.000511 |
European (Non-Finnish) | 0.00415 | 0.00401 |
Middle Eastern | 0.000526 | 0.000501 |
South Asian | 0.000135 | 0.000131 |
Other | 0.00288 | 0.00280 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Orexin and neuropeptides FF and QRFP bind to their respective receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.105
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- N
- hipred_score
- 0.486
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.196
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npffr1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;biological_process;cellular response to hormone stimulus
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;neuropeptide receptor activity